Viewing entries tagged
Digital Health


  • Record year for Talis Capital as it is now investing $100m of funds a year 

  • Talis helps successful entrepreneurs from all sectors invest in the next generation of tech startups and unicorns 

  • Total assets under advisory have increased by 220% in five years

  • Talis is a generalist technology VC and focus areas for 2019 include data, food/agritech, digital health and consumer

London, 27 June 2019 — Talis Capital, the venture capital investment firm that was an early investor in Darktrace, Pirate Studios, Luminance and iwoca, has raised a record $100m for 2019 as it celebrates a decade of successful investing in technology companies on behalf of its entrepreneurial investor base.

The latest raise catapults Talis Capital’s total transactions over 10 years to more than $600m, as it seeks to invest in the fast-growing tech companies that are disrupting established sectors, including food and farming, consumer and healthcare. 

Increasingly entrepreneurs from outside the tech sector want to invest in the companies of the future but need help to access the sector-defining deals that are creating some of the world’s fastest-growing tech companies. Talis, which blends the speed and flexibility of having a private investor base with the experience and networks of a venture capital fund, has seen its total assets under advisory increase by 220% in five years. 

It favours companies that are at an early stage in their growth but have long-term global potential and its track record includes fast-growing tech companies such as Darktrace, Onfido, iwoca, Pirate Studios, Luminance, and Clausematch. In the past 12 months alone, Talis has invested in Pricefx, Beyond, Edge Intelligence, Insurdata,The Learning People,, Omni:us, Oh My Green, The Plum Guide, Ynsect, Medbelle, Artemis, Zyper and others.

Matus Maar, Managing Partner & Co-Founder of Talis Capital: “The strength of our approach is based on two things: first we can move quickly to make decisions because our structure allows us to be agile, flexible and competitive in the fundraising process. Secondly, the investors who back us have had significant business success in their own right and they are prepared to leverage their networks to help our portfolio grow. We’ve consciously backed companies with the global potential to transform traditional industries significantly, using a technology-led or technology-enabled approach.”  


Founded in 2009, Talis was born out of Bob and Rohini Finch’s family office but quickly extended to include some of London and the world’s most successful entrepreneurs and ultra high net worth individuals, drawn from financial services, telecoms, commodities, industrials, leisure, retail, and real estate. The fund, run alongside the Finches by partners Vasile Foca and Matus Maar, raises money every year from its investor base and is achieving a run rate of 42% annual IRR and average 5x money multiple, by investing in technology-led and technology-enabled companies that are transforming established sectors. 

Talis’s team has skills and experience in building companies from concept stage right through to larger businesses. By investing across stages, from late seed to Series C, Talis has forged connections right across the tech sector and invests alongside some of the world’s biggest venture capital funds.

Investors participate in an annual vintage fund, but are also invited to double down on companies they particularly like by taking part in special purpose vehicles (SPVs), where Talis has secured a larger than normal allocation.

Vasile Foca, Managing Partner and Co-Founder of Talis Capital, said: “The investors we work closely with want to back the next generation of innovators and disruptors. We can show them how to do that, and at an early enough stage when they can really make a difference. One of the reasons why we are successful is because we seek entrepreneurs and ideas that we can be passionate about and can leverage this passion and conviction with our LPs. Talis Capital has its roots in a family office, but has grown to incorporate over 30 individuals and families to offer a gateway to the best of the European venture capital scene.”



Talis’s investments in the past year range from Luminance, an AI platform for the legal profession, to Oh My Green, a healthy food caterer to businesses. Other investments include cutting-edge cultivation management for farmers, Artemis, and the world’s first digital hospital, Medbelle.

In the year ahead, the company is looking to continue to invest along key themes, where it has conducted in-depth research and established expertise. These themes include data, insurtech and proptech. New areas of focus include:

  • ‘content to commerce’ - a category that encompasses bringing data-driven content to the consumer through innovative forms of publishing and media;

  • Digital healthcare - using innovation and technology to evolve the patient journey from diet and wellbeing through diagnosis to treatment and aftercare

  • Sustainable food and farming - tackling the global sustainability crisis - a category where it has recently participated in a $125m series C investment in insect protein farming company, Ynsect.

AI, deep learning, and automation technologies are increasingly important applications, and many of Talis’s portfolio companies incorporate aspects of this technology (e.g. Pirate Studios and iwoca). However, Talis is also keen on hybrid investments that straddle the analogue and the tech world. In the case of Pirate Studios, the business has physical studios which are booked and managed online. Musicians and artists can use Pirate Studios for rehearsals or recording and as a content platform, from which they can stream their live content and disseminate music, podcasts and performances.

Inspired and encouraged by some of the younger investors in the fund, Talis is also focusing hard on the preoccupations and changing habits of Gen Z, which it recognises as shaping emerging startups in both the consumer sector and other enterprise sectors.


Contact: / 07530 815 018

About Talis Capital

Talis Capital is a venture capital investment firm that takes smart money from some of the world’s most successful entrepreneurs and business people and invests it strategically in early-stage technology companies with global potential. Talis has invested over $600 million worth of transactions since 2009 and the portfolio includes Darktrace, Onfido, iwoca, Pirate Studios, Luminance, Threads, Ynsect and Oh My Green. Focused on building long-term partnerships, Talis leverages its network to give some of the world’s most innovative startups opportunity to thrive.

Talis Capital Limited (“Talis”) is an appointed representative of Privium Fund Management (UK) Limited (“Privium”). Privium is authorised and regulated by the Financial Conduct Authority of the United Kingdom (the “FCA”). The investment services of Talis are only available to professional clients and eligible counterparties for the purposes of the FCA’s rules. They are not available to retail clients. Past performance is not a guide to future performance and any capital invested is at risk.

Additional coverage:
Forbes - A point of difference

TechCrunch - Q&A with Talis

CityAM - Tech investor raises record $100m

Sifted, Tech.EU, EU startups, UKTN

Medbelle raises $7m (€6m) in Series A to Build World’s First Digital Hospital

Medbelle raises $7m (€6m) in Series A to Build World’s First Digital Hospital

  • Funding round led by signals Venture Capital, with other investors including Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and prior backer Cavalry Ventures

  • Announcement signals rapid expansion of ground-breaking, end-to-end digital patient care platform  

  • 30,000 Britons have already used new service to navigate their treatment journey, as founders on target to attract a further 144,000 users by 2020

  • Medbelle bringing greater efficiency and transparency to the previously fragmented and bureaucratic healthcare sector

London and Berlin,  April 2019 — Medbelle, the UK’s leading end-to-end platform for medical procedures, today announced $7m (€6m) in funding to accelerate the digitisation of the patient journey. The Series A funding round was led by signals Venture Capital and joined by Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and Cavalry Ventures.

Already covering the majority of the UK, and with its eye on international expansion, Medbelle’s three-layered ‘digital hospital’ model (Medbelle Platform, Medbelle Care, and Medbelle Operating System) places unprecedented control in the hands of patients, while giving healthcare professionals access to an integrated suite of management tools covering the entire treatment journey – from first consultation to billing, post-operative care and follow-up.

Patients book their procedure with Medbelle, which provides them with leading specialists and state-of-the-art operating facilities – with all organisation taken care of by the platform. The Medbelle service is designed to save them time, stress and money, ensuring that they benefit from the very best treatments and facilities available. Once a patient is registered, every aspect of their treatment is accessible via a single, simple web portal and app, or through their own personal Medbelle Care Adviser.

At the same time, the Medbelle Operating System ensures healthcare providers can make the most of their valuable time and resources. It allows specialists, hospitals and staff to work more productively, and liberates them from inefficient, unnecessary administrative tasks.    

Already enthusiastically backed by patients, with an outstanding Net Promoter Score (NPS) of 93 – making it the highest-rated medical provider in the UK – the cash injection will enable Medbelle to undertake the next phase of its roll-out. And with the UK private healthcare sector forecast to hit $13.8bn by 2023, it’s a market opportunity that has proven highly attractive to investors.

In its launch phase, Medbelle was focused on privately-paid (self-funded) procedures in areas such as cosmetics, bariatrics and ophthalmology and is currently expanding into orthopaedics and fertility. In the future, Medbelle will work with private medical and public insurance providers / the NHS to leverage its technology and services to help patients with all types of medical procedure.

“The new capital will accelerate the development of our platform while growing Medbelle’s operating footprint,” said Daniel Kolb, co-founder and MD of Medbelle. “It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients.”

Clemens Koós, investment manager at signals Venture Capital, said: “Major digital platforms improve customer experience in almost all industries, however, in healthcare, the digitisation of patient journeys has been heavily lagging behind until now. Medbelle’s technology and personalised care enable much simpler and more affordable medical treatments - while allowing healthcare providers to efficiently focus on treating patients. We look forward to working with the Medbelle team and co-investors in expanding the platform to include more treatment specialities and increasing its reach."

Vasile Foca, Managing Partner at Talis Capital, said: “The digital health market is expected to reach $536bn by 2025 – so the time is right to be focusing on technologies that can transform healthcare and the patient journey as we know it today. We’re proud to be backing Leander, Daniel and their high-quality team in this latest round as they roll out their truly digital treatment solution. Medbelle is the world’s first digital hospital that creates real value for both patients and providers and offers unrivalled care from some of the country’s best specialists.”

Leander de Laporte, co-founder and MD at Medbelle, said: “The ‘digital hospital’ creates real value for patients and healthcare providers alike and, therefore, can offer care from the best specialists in the country with a truly digital and personal experience. It’s great to have new partners on board who bring such vast experience to the table. We all agree that an integrated model enables much faster deployment of technology to improve patient experience and reduce costs.”

-Ends -


About Medbelle: Medbelle is the first digital hospital - an end-to-end platform for medical procedures. We strive to create a world in which patients navigate their treatment journey digitally and receive personal care at the click of a button.
We have integrated the entire patient journey to deliver a frictionless treatment experience for patients: We hire surgeons, rent operating facilities and provide a platform to streamline patient data, communication, provider selection, treatment pricing, scheduling and more. At the same time, our platform reduces workload and optimises utilisation of specialist doctors and hospitals. Our technology, patient care team and high-quality hospitals & specialists have garnered an industry-leading Net Promoter Score of 93 and have allowed us to help more than 30,000 patients all over the UK. Visit for details.

About Talis Capital: Talis Capital is a venture capital investment firm that takes smart money from some of the world’s most successful entrepreneurs and business people and invests it strategically in early stage technology companies with global potential. Talis has invested over $500m worth of transactions since 2009 and the portfolio includes Darktrace, Onfido, iwoca, Pirate Studios, Luminance, Ynsect and Oh My Green. Focused on building long-term partnerships, Talis leverages its network to give some of the world’s most innovative startups opportunity to thrive. For more see

About signals Venture Capital: signals Venture Capital is an early stage investor backed by

a €100m venture capital fund with a focus on forward-looking, scalable technology solutions that can transform or disrupt entire industries. signals Venture Capital invests in companies active in disruptive industries such as health, mobility and financial services as well as b2b business models all over Europe and Israel, especially in the field of Data & Analytics, Artificial Intelligence and Internet of Things. The portfolio companies profit not only from the classic venture capital support but also from the extensive ecosystem with renowned German and European partners, industry experts and diverse distribution channels.

About IBB Beteiligungsgesellschaft: IBB Beteiligungsgesellschaft ( provides venture capital to innovative Berlin-based companies and has established itself as a market leader in the field of early-stage financing in Germany. The funds are used primarily for the development and market launch of innovative products or services, as well as for business concepts of creative industries. Currently, two of the funds managed by the IBB Beteiligungsgesellschaft are in the investment phase, the VC Fonds Technologie Berlin II with a fund size of 60 million euros and the VC Fonds Kreativwirtschaft Berlin II with a fund size of 40 million euros. Both VC funds are financed by means of the Investitionsbank Berlin (IBB) and the European Fund for Regional Development (EFRE) administered by the State Berlin. Since 1997 the IBB Beteiligungsgesellschaft, in consortia with partners, has made 1.43 billion euros available to creative and technology-orientated companies; thereof, the portion invested by IBB Beteiligungsgesellschaft itself, as lead, co-lead or co-investor, was approximately 200 million euros.

About Mutschler Ventures: Mutschler Ventures is the venture arm of a Zurich based family office, actively investing in start-up companies in the digital as well as blockchain world. Over the past years, Mutschler Ventures has been invested in e.g., later, Adyen, McMakler, Auto1, Sygnum, Loanboox and other companies in the German-speaking region.

About Cavalry Ventures: Cavalry Ventures is an entrepreneurially driven VC fund based in Berlin with a focus on angel and seed-stage investments in Europe. The six founding Partners have repeatedly financed, founded, built and sold market-leading companies such as Delivery Hero, Tradeshift or plista. Being both, experienced investors and still active entrepreneurs, the cavalry offers hands-on support and a strong value-add to ambitious founders of fast-growing technology companies.